Phase III Adjuvant Chemotherapy with Intensive CEF (CTX/EPI/5-FU) vs Standard CMF (CTX/MTX/5-FU) in Premenopausal Patients with Carcinoma of the Breast with Positive Axillary Nodes

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Basic Trial Information

PhaseTypeStatusAgeSponsorProtocol IDs
Phase IIITreatmentClosedpre/perimenopausalCAN-NCIC-MA5
NCI-V90-0027, MA5

Trial Contact Information

Trial Lead Organizations

NCIC-Clinical Trials Group

Mark Levine, MD, Protocol chair (Contact information may not be current)
Ph: 905-527-4322 ext. 42176